Suppliers

Date：2021-07-28 Views： 25 Times

Recent Posts

Susvimo (PDS with ranibizumab) is approved by FDA treatment for neovascular or “wet” age-related macular degeneration (nAMD) 2021年10月23日
Opdivo (nivolumab) + Chemotherapy is approved by the European Commission for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma 2021年10月23日
Brukinsa (zanubrutinib) is approved in the Russia to treat patients with relapsed or refractory mantle cell lymphoma (MCL) 2021年10月22日
Digital Therapeutic Luminopia One is approved in the US for Improve Vision in Children with Amblyopia 2021年10月21日
FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines 2021年10月21日

Susvimo (PDS with ranibizumab) is approved by FDA treatment for neovascular or “wet” age-related macular degeneration (nAMD)
Opdivo (nivolumab) + Chemotherapy is approved by the European Commission for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma
Brukinsa (zanubrutinib) is approved in the Russia to treat patients with relapsed or refractory mantle cell lymphoma (MCL)
Digital Therapeutic Luminopia One is approved in the US for Improve Vision in Children with Amblyopia
FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
On/Go™(AI-powered mobile app) is authorized by FDA rapid COVID-19 self-test unique